September 7, 2022
PA-20-188 - NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
PAR-21-271 - Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
Effective with awards issued in Fiscal Year 2023 (FY2023), NIGMS will raise the maximum salary, research and total support levels provided on NIGMS K99 awards through the Parent and MOSAIC funding opportunity announcements.
NIGMS K99 award levels will be:
Up to $75,000 plus fringe benefits per year (increased from $60,000). As always, salary must be consistent with effort committed to the award and institutional compensation policies.
Up to $25,000 per year (increased from $20,000).
The total cost for the mentored phase (K99) may not exceed $125,000 per year (increased from $100,000).
The total cost maximum of $249,000 per year for the R00 phase is unchanged.
This change in support levels provided for the K99 phase will become effective with the FY2023 start date of new (competing) awards, and with the FY2023 anniversary of the start date for non-competing awards.
Budget requests in applications submitted on or after the October/November 2022 application due dates should utilize these new support levels, as applicable.
For applications recommended for funding following review at the October 2022 or January 2023 National Advisory General Medical Science Council meetings, NIGMS staff will contact applicants about the opportunity to request an increase in support up to these new levels.
For FY2023 Research Performance Progress Reports (RPPRs), awardees should utilize section H.1 (Budget Form) of the RPPR to request an increase in support up to these new levels, as applicable.